Genix Pharmaceuticals Corp
XTSX:GENX

Watchlist Manager
Genix Pharmaceuticals Corp Logo
Genix Pharmaceuticals Corp
XTSX:GENX
Watchlist
Price: 0.02 CAD Market Closed
Market Cap: CA$1.2m

Genix Pharmaceuticals Corp
Investor Relations

Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.

Show more
Loading
GENX
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Mahmoud S. Aziz
Chairman of the Board & President
No Bio Available
Mr. Sina Salehi Pirooz
CEO & Director
No Bio Available
Mr. Wayne Kent Lee CA, CPA
Chief Financial Officer
No Bio Available
Mr. Kevin James Bottomley
Director of Corporate Development & Independent Director
No Bio Available
Ms. Monita Franziska Valeska Faris
Company Secretary
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
Suite 300, 1055 West Hastings Street
Contacts
+16047109461.0